Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: Influence of fatty and non-fatty additives

References

• Alléman E., Gurny R., Leroux J.-C. Biodegradable nanoparticles of PLA and PLGA for parenteral administration. Pharmaceutical Dosage Forms: Disperse Systems, 2nd edn, H. A. Lieberman, M. M. Rieger, G. S. Banker. Marcel Dekker, New York 1998
   Google Scholar
• Álvarez C., Herrero-Vanrell R., Negro S., Molina I. T., Hernández M. T., Pastoriza P., Barcia E. Dexametasone microspheres for intravitreal administration. 3rd Spanish Portuguese Conference on Controlled Drug Delivery. 1998; 83
   Google Scholar
• Beck L. R., Cowsar D. R., Lewis D. H., Cosgrove R. J., Riddle C. T., Lowry S. L., Epperly T. A new long-acting injectable microcapsule system for the administration of progesterone. Fertility and Sterility 1979; 31: 545–548
   PubMed Web of Science ®Google Scholar
• Brayfield A. Martindale, 32nd edn. Pharmaceutical Press, London 1999
   Google Scholar
• Brigden D., Whiteman P. The clinical pharmacology of acyclovir and its prodrugs. Scandinavian Journal of Infectious Diseases Supplementum 1985; 47: 33–39
   PubMedGoogle Scholar
• Chowdhury D. K., Mitra A. K. Kinetics of a model nucleoside (guanosine) release from biodegradable poly (DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery. Pharmaceutical Development and Technology 2000; 5: 279–285
   PubMed Web of Science ®Google Scholar
• Cohen S., Yoshiaka T., Lucarelli M. Controlled delivery system for proteins based on poly (lactic/glycolic acid) microspheres. Pharmaceutical Research 1991; 8: 713–720
   PubMed Web of Science ®Google Scholar
• Conti B., Bucolo C., Giannavola C., Puglisi G., Giunchedi P., Conte U. Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/ in vivo evaluation. European Journal of Pharmaceutical Sciences 1997; 5: 287–293
   Web of Science ®Google Scholar
• Gao Z., Shukla A. J., Johnson J. R., Crowley W. R. Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vitro evaluation. Pharmaceutical Research 1995; 12: 857–863
   PubMed Web of Science ®Google Scholar
• Genta I., Conti B., Perugini P., Pavanetto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. Journal of Pharmacy and Pharmacology 1997; 49: 737–742
   PubMed Web of Science ®Google Scholar
• Gursoy A., Cevik S. Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium. Journal of Microencapsulation 2000; 17: 565–575
   PubMed Web of Science ®Google Scholar
• Herrero-Vanrell R., Refojo M. F. Biodegradable microspheres for vitreoretinal drug delivery. Advanced Drug Delivery Reviews 2001; 52: 5–16
   PubMed Web of Science ®Google Scholar
• Herrero-Vanrell R., Barcia E., Negro S., Refojo M. F. Development of ganciclovir microspheres from poly (D, L-lactic-co-glycolide) acid for the treatment of AIDS-related cytomegalovirus retinitis. STP Pharma Sciences 1998; 8: 237–240
   Google Scholar
• Herrero-Vanrell R., Ramirez L., Fernández-Carballido A., Refojo M. F. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Pharmaceutical Research 2000; 17: 1323–1328
   PubMed Web of Science ®Google Scholar
• Hughes P. M., Krishnamoorthy R., Mitra A. K. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. Journal of Ocular Pharmacology and Therapeutics 1996; 12: 209–224
   PubMed Web of Science ®Google Scholar
• Jalil R., Nixon J. R. Biodegradable poly(lactic acid) and poly(lactic-coglycolide) microcapsules: problems associated with preparative techniques and release properties. Journal of Microencapsulation 1990; 7: 297–325
   PubMed Web of Science ®Google Scholar
• Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Controlled release rate of bleomycin from poly(lactic) acid microspheres by additives. Chemical and Pharmaceutical Bulletin 1985; 33: 1609–1614
   PubMed Web of Science ®Google Scholar
• Khidr S. H., Niazy E. M., El-Sayed M. Development and in-vitro evaluation of sustained-release meclofenamic acid microspheres. Journal of Microencapsulation 1998; 15: 153–162
   PubMed Web of Science ®Google Scholar
• Lalla J. K., Sapna K. Biodegradable microspheres of poly (DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. Journal of Microencapsulation 1993; 10: 449–460
   PubMed Web of Science ®Google Scholar
• Mallard C., Coudane J., Rault I., Vert M. In vitro delivery of a sparingly water soluble compound from PLA 50 microparticles. Journal of Microencapsulation 2000a; 17: 13–28
   PubMedGoogle Scholar
• Mallard C., Coudane J., Rault I., Vert M. The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA 50 microspheres. Journal of Microencapsulation 2000b; 17: 81–93
   PubMed Web of Science ®Google Scholar
• Reed A. M., Gilding D. K. Biodegradable polymers for use in surgery, Poly(glycolic)/poly (lactic acid) homo and copolymers: 2. In vitro degradation. Polymer 1981; 22: 494–498
   Web of Science ®Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 1987; 5: 23–36
   Google Scholar
• Sansdrap P., Möes A. J. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres. Journal of Microencapsulation 1998; 15: 545–553
   PubMed Web of Science ®Google Scholar
• Tice T. R., Gilley R. M. Preparation of injectable controlled-release microcapsules by a solvent-evaporation process. Journal of Controlled Release 1985; 2: 343–352
   Google Scholar
• Wang Y. M., Sato H., Adachi I., Horikoshi I. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. Chemical Pharmaceutical Bulletin 1996; 44: 1935–1940
   PubMed Web of Science ®Google Scholar